Table 3.
Summary reports of acute ischemic stroke following the COVID-19 vaccination with whole inactivated virus vaccines.
Author(s) | No. of cases | vaccine dose | Age gender | Past medical history/medication(s) | Time from vaccination (days) | Clinical presentation | Imaging findings | Lab findings | Treatment/outcome |
---|---|---|---|---|---|---|---|---|---|
BIBP (Sinopharm) | |||||||||
G. Elaidouni et al. [60] | 1 | First | 36 male | HTN, DM, dyslipidemia, smoker/clopidogrel | 2 | headaches, left hemiplegia, left facial paralysis, left hemibody hypotonia, impaired consciousness | superficial and deep right parietal infarction | Platelets count and D-dimer: NL | ASA, Enoxaparine/alive |
Sinovac | |||||||||
R. Hidayat et al. [61] | 3 | First | 77 male | CAD, DM, HTN, ischemic stroke | 0 | left lower limb hemiparesis, slurred speech | several infarctions in bilateral centrum semiovale, cortical-subcortical right frontal and temporal lobe, bilateral external capsule, and right pons | Platelets count: NL | ASA, Clopidogrel/alive |
First | 79 male | HTN, hypercholesterolemia, ex-smoker | 2 | left hemiparesis | lacunar infarcts in right frontoparietal region | Platelets count: NL | ASA/alive | ||
First | 62 male | HTN, ischemic stroke | 1 | left hemiparesis, slurred speech, and facial asymmetry | watershed infarctions in right centrum semiovale and corona radiata | Platelets count: NL, normal D-dimer | ASA, Clopidogrel/alive |
NL: normal; N/A: not available; DM: diabetes mellitus; HTN: hypertension; CAD: coronary artery disease; ASA: acetylsalicylic acid (aspirin).